Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Emerging Therapy

Study: New Engineered Particles Train the Body to Accept Allergens

FDA Delays Approval of Aquestive’s Anaphylm™ Sublingual Epinephrine Film

Nasus Pharma’s Nasal Epinephrine Powder Shows Faster Relief Than EpiPen

GSK’s $2.2 Billion Acquisition of Rapt Signals a New Era for Food Allergy Treatments

Beyond Desensitization: How PRT120 Rewires the Immune System for Peanut Allergy Remission

Have Researchers Found a Way to Prevent Allergic Reactions Before They...

Company Developing Novel Food Allergy Treatment Raises $3.5 Million in Seed...

Aimmune Issues Update on AR101 Peanut Oral Immunotherapy Candidate

Study: Drug Increases Speed and Safety of OIT for Multiple Allergies

Phase I Trial of Epinephrine Nasal Spray for Anaphylaxis Begins

Study: The Effect of OIT in Severe Milk, Peanut and Egg...

Positive Safety Results Reported for Viaskin Peanut Phase III Trial

Study: Nine Children Suffer Severe Symptoms in OIT Trial

Viaskin Peanut Phase III Trial Falls Short, Still Chance for FDA...

Aimmune, Regeneron and Sanofi Collaborate on Combination Peanut Therapy

Your School On Our Map

Put Your School on the Map